Predictors of the effectiveness of the treatment of symptoms of the chronic painful form of diabetic polyneuropathy with the use of alpha-lipoic acid
https://doi.org/10.14341/probl201359114-17
Abstract
References
1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 5-й выпуск. Сахарный диабет 2011; 3: (приложение).
2. Attal N., Cruccu G., Baron R., Haanpää M., Hansson P., Jensen T., Nurmikko T. European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-1188.
3. Bril V., England J., Franklin G., Backonja M., Cohen J., Del Toro D., Feldman E., Iverson D., Perkins B., Russell J., Zochodne D. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758-1765.
4. Tesfaye S., Boulton A., Dyck P., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R., Spallone V., Vinik A., Bernardi L., Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293.
5. Boulton A., Freeman R., D'Urso De Cruz. Are patient characteristics predictive of a response to pregabalin? Analysis from 5 randomized, placebo-controlled trials in painful diabetic peripheral neuropathy. Diabetologia 2006; 49: Suppl 1: 668-669.
6. Храмилин В.Н., Демидова И.Ю., Игнатова О.Ю. Оценка эффективности различных режимов пероральной терапии альфа-липоевой кислотой болевой формы диабетической периферической полинейропатии. Сахарный диабет 2010; 2: 28-32.
7. Tesfaye S., Vileikyte L., Rayman G., Sindrup S., Perkins B., Baconja M., Vinik A., Boulton A. on behalf of the Toronto Expert Panel on Diabetic Neuropathy. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabetes. Metabol Res Rev 2011; 27: 629-638.
8. Oyibo S., Prasad Y., Jackson N., Jude E., Boulton A. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002; 19: 870-873.
9. Ziegler D., Nowak H., Kempler P., Vargha P., Low P. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a metaanalysis. Diabet Med 2004; 21: 114-121.
10. Ziegler D., Low P., Boulton A. Effect of 4-year antioxidant treatment with alpha-lipoic acid in diabetic polyneuropathy: The NATHAN 1 Trial: Аbstract. Diabetes 2007; 56: A2.
Review
For citations:
Khutornaia O.E., Bregovskiĭ V.B., Demina A.G., Karpova I.A., Grineva E.N. Predictors of the effectiveness of the treatment of symptoms of the chronic painful form of diabetic polyneuropathy with the use of alpha-lipoic acid. Problems of Endocrinology. 2013;59(1):14-17. https://doi.org/10.14341/probl201359114-17
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
